Supportive Care in Cancer

, Volume 13, Issue 10, pp 806–811 | Cite as

Prevalence of complementary and alternative medicine use in cancer patients during treatment

  • Jennifer S. Yates
  • Karen M. Mustian
  • Gary R. Morrow
  • Leslie J. Gillies
  • Devi Padmanaban
  • James N. Atkins
  • Brian Issell
  • Jeffrey J. Kirshner
  • Lauren K. Colman
Original Article


Goals of work

To assess complementary and alternative medicine (CAM) therapies being utilized by cancer patients during treatment and communication about CAM usage between the patient and physician.

Patients and methods

Newly diagnosed cancer patients receiving chemotherapy or radiation therapy were recruited to complete a CAM survey within 2 weeks after the termination of treatment. Patients were queried on which CAM modalities they utilized and whether or not they were discussed with either their oncologist or primary care physician.

Main results

Of the patients surveyed, 91% reported using at least one form of CAM. The most widely used forms of CAM were prayer, relaxation and exercise. CAM users tended to be women chemotherapy patients with at least a high school education. Of the patients using CAM, 57% discussed the use of at least one of these therapies with their oncologist or primary care physician. The most frequent CAM modalities discussed with at least one physician were diets, massage, and herbal medicine.


An overwhelming proportion of cancer patients are using CAM, particularly prayer, relaxation, and exercise. However, patients may not discuss the use of CAMs at all or fully with their physician; if they do, it is most likely to be their oncologist, but not about the most frequently used CAMs. Future research needs to assess effective ways for oncologists to gather information about CAM usage by patients during allopathic treatment and discern ways these therapies may enhance or interfere with traditional cancer treatments.


Complementary medicine Quality of life Symptom management Behavioral medicine 


  1. 1.
    Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 48:453–458PubMedGoogle Scholar
  2. 2.
    American Cancer Society (2005) Statistics for 2004.
  3. 3.
    Balneaves LG, Kristjanson LJ, Tataryn D (1999) Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns 38:143–153Google Scholar
  4. 4.
    Begbie SD, Kerestes ZL, Bell DR (1996) Patterns of alternative medicine use by cancer patients. Med J Aust 165:545–548Google Scholar
  5. 5.
    Bernstein BJ, Grasso T (2001) Prevalence of complementary and alternative medicine use in cancer patients. Oncology 15:1267–1272Google Scholar
  6. 6.
    Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515–2521PubMedGoogle Scholar
  7. 7.
    Canales MK, Geller BM (2003) Surviving breast cancer: the role of complementary therapies. Fam Commun Health 26:11–24Google Scholar
  8. 8.
    Dooley MJ, Lee DY, Marriott JL (2004) Practitioners’ sources of clinical information on complementary and alternative medicine in oncology. Support Care Cancer 12:114–119Google Scholar
  9. 9.
    Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89PubMedGoogle Scholar
  10. 10.
    Ernst E (2000) The role of complementary and alternative medicine in cancer. Lancet Oncol 1:176–180Google Scholar
  11. 11.
    Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777–782CrossRefPubMedGoogle Scholar
  12. 12.
    Feather BL, Wainstock JM, Remington A, Ringenberg QS (1988) Postmastectomy educational needs and social support. J Cancer Educ 3:135–144Google Scholar
  13. 13.
    Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 10:52–57Google Scholar
  14. 14.
    Jordan ML, Delunas LR (2001) Quality of life and patterns of nontraditional therapy use by patients with cancer. Oncol Nurs Forum 28:1107–1113Google Scholar
  15. 15.
    Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47CrossRefPubMedGoogle Scholar
  16. 16.
    Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE (2002) Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 29:1445–1452PubMedGoogle Scholar
  17. 17.
    Morris KT, Johnson N, Homer L, Walts D (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179:407–411CrossRefPubMedGoogle Scholar
  18. 18.
    Morrow GR, Hickok JT, Burish TG, Rosenthal SN (1996) Frequency and clinical implications of delayed nausea and delayed emesis. Am J Clin Oncol 19:199–203CrossRefPubMedGoogle Scholar
  19. 19.
    Munstedt K, Kirsch K, Milch W, Sachsse S, Vahrson H (1996) Unconventional cancer therapy—survey of patients with gynecological malignancy. Arch Gynecol Obstet 258:81–88CrossRefPubMedGoogle Scholar
  20. 20.
    Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA (2004) An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 22:671–677Google Scholar
  21. 21.
    NCCAM (2002) What is complementary and alternative medicine (CAM)? (publication no. D156). NCCAM, National Institutes of Health, Bethesda, MDGoogle Scholar
  22. 22.
    Newell S, Sanson-Fisher RW (2000) Australian oncologists’ self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. Med J Aust 172:110–113Google Scholar
  23. 23.
    Ott MJ, Lynch M (2002) Integrating complementary and conventional symptom management in a cancer center. Oncol Nurs Forum 29:25–27Google Scholar
  24. 24.
    Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8:477–485Google Scholar
  25. 25.
    Ponholzer A, Struhal G, Madersbacher S (2003) Frequent use of complementary medicine by prostate cancer patients. Eur Urol 43:604–608Google Scholar
  26. 26.
    Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14:275–290Google Scholar
  27. 27.
    Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMedGoogle Scholar
  28. 28.
    Richardson MA, Straus SE (2002) Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol 29:531–545CrossRefPubMedGoogle Scholar
  29. 29.
    Risberg T, Kaasa S, Wist E, Melsom H (1997) Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 33:575–580CrossRefPubMedGoogle Scholar
  30. 30.
    Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19:895–908Google Scholar
  31. 31.
    Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J (2000) Use of complementary medicine by adult patients participating in cancer control trials. Oncol Nurs Forum 27:623–630Google Scholar
  32. 32.
    Verhoef MJ, Hilsden RJ, O’Beirne M (1999) Complementary therapies and cancer care: an overview. Patient Educ Couns 38:93–100Google Scholar
  33. 33.
    White JD (2002) Complementary and alternative medicine research: a National Cancer Institute perspective. Semin Oncol 29:546–551Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Jennifer S. Yates
    • 1
    • 6
  • Karen M. Mustian
    • 1
  • Gary R. Morrow
    • 1
  • Leslie J. Gillies
    • 1
  • Devi Padmanaban
    • 1
  • James N. Atkins
    • 2
  • Brian Issell
    • 3
  • Jeffrey J. Kirshner
    • 4
  • Lauren K. Colman
    • 5
  1. 1.James P. Wilmot Cancer CenterUniversity of RochesterRochesterUSA
  2. 2.Southeast Cancer Control ConsortiumWinston-SalemUSA
  3. 3.Cancer Research Center of HawaiiHonoluluUSA
  4. 4.Syracuse Hematology-Oncology CCOPSyracuseUSA
  5. 5.Northwest CCOPTacomaUSA
  6. 6.University of Rochester Cancer CenterRochesterUSA

Personalised recommendations